Last year, Medtronic released data that linked the MiniMed 780G insulin pump to significant improvements in blood glucose levels and time in target range compared to manual multiple daily injections (MDI). Now, Medtronic has released data from the second part of the study. The patients using MiniMed 780G from the start of the trial continued to use the pump and retained the improvements they experienced over the first six months. …
Intermittent fasting (IF), defined as fasting for more than eight hours at a time, is a trend that is growing in popularity. Yet new research shows it may be linked …
The Association of British Clinical Diabetologists (ABCD) has announced that five diabetes and endocrinology professionals have been appointed to the ABCD academic subcommittee: Professor Mark Evans; Dr Ben Field; Professor …
Innovation Zed has announced that it has secured a CE Mark for its InsulCheck DOSE add-on device. InsulCheck DOSE is a single-unit add-on device compatible with all pen injectors that …
Abbott plans to offer updated FreeStyle Libre 2 and Libre 3 sensors in the US later this year, replacing its current systems. Automated insulin delivery (AID) systems include an insulin …
Diabetes UK Sheffield are holding a big event about Diabetes and Tech on Saturday May 13th; speakers include Nerdabetic, Kamil Armacki, Diabetech’s Tim Street, and the clinician and academic Professor …
ukactive’s pilot study to transform leisure centres, swimming pools, and gyms into musculoskeletal (MSK) health hubs has been expanded to 100 sites across the UK. The pilot forms part of …
New documentary film The Human Trial provides unprecedented, real-time access to a radical stem cell treatment can now be watched in the UK. Driven to find a cure for her …
Beyond Type 1 co-founder Nick Jonas appeared on the Today Show to announce that Dexcom and Beyond Type 1 have pledged $1 million to help address health equity and continue …
Aston University scientists have discovered a more accurate way of checking the blood flow in the feet of patients with Type 2 diabetes. Using lasers, their findings have resulted in …
More than 30,000 patients with Type 1 diabetes across the UK Midlands now have access to life-changing continuous glucose monitoring technology, thanks to cost-effective deals secured for patients and rapidly …
The US Food and Drug Administration has approved Abbott’s Proclaim XR spinal cord stimulation (SCS) system for the treatment of patients with diabetic peripheral neuropathy (DPN). Diabetic neuropathy is the …
Patient numbers published recently by the independent OCL Vision eye clinic reveal a surging demand for private eye surgery as NHS waiting lists break new records. Since launching four years …
As icy cold snaps make for challenging conditions on the roads, a high street optician is urging people to ‘get themselves seen’ after more than a quarter of customers admitted …
Another recent survey on eye care – this time by polling organisation YouGov – has concluded that the pandemic and cost-of-living crisis are having a worrying impact on Britain’s eye …
The January and February cold snaps saw temperatures drop below freezing in certain areas of the UK, but a free support service called the Priority Services Register is providing help …
The Royal Mail has teamed up with Pharmacy2U, the UK’s largest online pharmacy, to offer a complete NHS prescription service that enables patients to order all their NHS prescription needs …
Ypsomed and Mediq are completing the sale of DiaExpert. Ypsomed and Mediq had announced the agreement on the sale of DiaExpert on 28 October 2022. After all approvals had been …
Oramed Pharmaceuticals has announced that it has received a new patent for its oral diabetes treatment. The patent covers oral pharmaceutical compositions comprising insulin in combination with glucagon-like peptide 1 …
The US Food and Drug Administration has approved a new medication for Type 2 diabetes called Brenzavvy. This belongs to a class of drugs known as SGLT-2 inhibitors, which work …
A small potential increased risk of retinopathy worsening after one year for those with Type 2 diabetes following injections of the GLP-1 agonist semaglutide does not outweigh the drug’s cardiovascular …
Dexcom has announced that it has appointed Teri Lawver to its newly created role of chief commercial officer (CCO). Lawver’s position oversees the global commercial organization at the continuous glucose …
The self-management of diabetes can be tiring and tough on mental health but a key benefit of peer support is access to help from peers who also deal with such …
Embecta has added an all-in-one, push-button fingerstick glucose reader to its portfolio. Launched this past April as a spinout from medtech giant BD, Embecta has signed an agreement with Intuity …
ABCD (Diabetes Care) Ltd have announced that the new Chair of ABCD will be Professor Ketan Dhatariya, who will take over from Dr Dipesh Patel in June 2023. Prof Dhatariya …
New results from a first-of-its-kind survey by Abbott has identified a clear disconnect between the perceptions of the British public and those living with diabetes when it comes to stigma …
Recruitment has opened for a trial screening programme for Type 1 diabetes that will identify children at high risk of developing the condition, laying the groundwork for the development of …
Could you help a team of researchers at the University of Southampton who are exploring mental health issues for people with Type 1 diabetes or Type 2 diabetes? If you …
Diabeloop and EOFlow have announced that are partnering to offer the latter’s EOPatch system with automated insulin delivery in Europe. The partnership combines the EOPatch, a third-party continuous glucose monitor …
The DRWF United Through Diabetes event will be taking place at Chesford Grange conference hotel in Kenilworth, Warwickshire, on Saturday 16 September 2023. The event will replace the charities educational …
W8Buddy (WeightBuddy), a new digital support tool that can help patients achieve clinically meaningful weight loss, has been launched by University Hospitals Coventry and Warwickshire NHS Trust. Developed by DDM …
Seattle-based Know Labs has announced that it has received a new patent equating its diagnostic technology to the current glucose monitoring (CGM) standard. Know Labs has developed Bio-RFID technology which …
Diabetes tech startup Harald AI has launched the popular Happy Bob App in Europe and in Canada, giving more ways for users of Dexcom Continuous Glucose Monitoring (CGM) Systems to …
So, that’s January nearly over but now the days are getting longer and I sense a teeny bit of spring in the air. Despite downtime for the festive season, there’s …
Early research suggests that aspartame, an artificial sweetener commonly found in diet drinks and food, may raise the risk for anxiety, according to a recent report in Medscape and published …
New data suggests that Metformin may help reduce risk for total joint replacement in patients with Type 2 diabetes. According to findings published in the Canadian Medical Association Journal, the study …
Beta Bionics has hired Steven Russell as chief medical officer. The change comes as Beta Bionics works to secure US Food and Drug Administration (FDA) clearance for its pocket-sized, wearable …
Need to figure out how much insulin to administer throughout the day and stick to those fluctuating doses over time? There’s now an app for that. Patients who don’t use …
An NHS England study in children and young people has showed improvements in glycaemic control, time in range, frequency of hypoglycaemia, hypoglycaemia fear and quality of sleep for children and …
Research is vital in providing the evidence needed to transform services and improve outcomes, such as in developing new models of care, redesigning urgent and emergency care, strengthening primary care …
Although half of patients with Type 2 diabetes (T2D) in France have blood glucose levels that are outside of their target range, an international consensus suggests that modern-day medicines now make remission …
A retrospective study has linked participation in Onduo’s virtual program for managing Type 2 diabetes to reductions in blood glucose. Researchers at Quest Diagnostics analysed the impact of Onduo on …
Sernova has provided an update on trials of its Cell Pouch System – an implantable and scalable medical device which forms a natural environment in the body for therapeutic cells …
Finding effective and safe drugs that can tackle obesity — achieving a substantial amount of weight loss without serious side effects — has proved challenging to date. In the United …
Tandem Diabetes Care, Inc. has entered into a definitive agreement to acquire AMF Medical SA, the privately held Swiss developer of the Sigi™ Patch Pump. The Sigi Patch Pump, which …
In draft guidance, an independent NICE committee has recommended the use of hybrid closed loop systems for managing blood glucose levels in Type 1 diabetes – technology that has been …
Highly processed foods meet the same criteria as tobacco for addiction and labeling them as such might benefit public health, according to a new US study that also proposes a …
Good nutrition is foundational to preventing chronic disease and helping people live a healthier life, yet physicians responding to a Medscape Medical News survey said they believe that only about …
An award-winning diabetes nursing group has launched two educational resources to mark World Diabetes Day on November 14th. Trend Diabetes, which represents all diabetes nursing groups, has launched its own …
A new study has reported that slowly lowering weights builds and strengthens muscles almost as well as lifting and lowering them. That means, for example, using two hands to lift …
BIOCORP has announced that they have received 510(K) clearance from the U.S. Food & Drug Administration (FDA) to market Mallya, its smart sensor that is directly attached to insulin pen …
Natalie Sainz, in diaTribe Learn, reports that a new international consensus of recommendations for the standard use of continuous glucose monitoring (CGM) data in clinical trials has been published in …
The FDA has now approved the use of teplizumab (Tzield), the world’s first ever immunotherapy for Type 1 diabetes, by people at risk of Type 1 diabetes. A clinical trial …
At-home tests, once considered an anomaly, became de rigueur during the COVID-19 pandemic. Now, as COVID-19 testing rates decline from their pandemic peak, diagnostic companies businesses are seeing an opportunity …
After analyzing 600 people wearing a continuous glucose monitor for an average of 12 days, Klick Applied Sciences says it can use data with artificial intelligence (AI) to identify healthy, prediabetic …
Novo Nordisk has announced that UK users of the Abbott FreeStyle LibreLink app can now connect to its smart insulin pens. People living with diabetes in the United Kingdom can …
Eli Lilly has pulled out of a partnership with Ypsomed that would have given it a branded insulin pump to sell in the U.S. Lilly struck a deal two years …
According to a study published in The New England Journal of Medicine, the ability to customize open-source, “do-it-yourself” automated insulin delivery (AID) systems may make them more effective at controlling …
Ascensia Diabetes Care has announced that it has updated its Eversense Continuous Glucose Monitoring system app to integrate with Apple Health. The new Apple Health integration will allow people with …
Roche has announced the introduction of the Navify brand to its digital health portfolio, which includes more than 30 digital solutions for labs, hospitals, and patients worldwide. Navify digital solutions …
Sernova’s Cell Pouch System is an implantable and scalable medical device that forms a natural environment in the body for the long-term survival and function of therapeutic cells. These cells …
The substantial increase in obesity prevalence in the United States – from 30.5% to 41.9% in just the 2 decades from 2000 to 2020 – has likely contributed to increases …
This is our last issue of this year, and what a year it has been in the diabetes world in general and in the UK specifically. I’m not sure many …
Compared with BMI’s relatively quick acceptance into clinical practice, obesity has only recently been recognised as a disease. Historically, obesity has been viewed negatively as a lifestyle choice, and the …
A recent study has found that patients with Type 1 diabetes had an increased risk of obstructive sleep apnoea. The study found that the risk factors for obstructive sleep apnoea …
Phil Aird-Mash, CEO of the ITC Travel Group, Chair of ACC Aviation and Traveltek Ltd, has been appointed JDRF’s Chair of the Board of Directors. Phil has served on the …
BHR markets and supports the use of their point of care diagnostic products for use in GP surgeries, hospitals and other locations, and is now expanding the ‘use at home’ …
Adocia has announced the establishment of a first proof of concept for its’ AdoShell Islets implant by achieving glycaemic control without insulin injections or immunosuppression in diabetic rats, following a …
The charity Diabetes Research and Wellness Foundation (DRWF) will be back in Hartlepool for our first Diabetes Wellness Day North since 2019 when it will be returning to The National …
Medtronic has announced positive results from a study of its next-generation MiniMed 780G automated insulin delivery system. Its ADAPT study enlisted 82 individuals with Type 1 diabetes who were not …
Study may explain why people with diabetes may develop tooth decay. People with both Type 1 and Type 2 diabetes are prone to tooth decay, and a new study from …
Apollo Endosurgery, Inc. has announced the publication of the results of a landmark ESG Randomized Interventional Trial (MERIT) Study in The Lancet. While bariatric surgery is the most successful treatment …
A recent trial has linked Abbott’s FreeStyle Libre 2 continuous glucose monitor (CGM) to significantly lower blood sugar levels than fingerstick testing. The study, published in The New England Journal …
Dexcom, a global leader in real-time continuous glucose monitoring, is inviting members of the diabetes community to express their unique journey with diabetes by creating custom Dexcom CGM patches via …
DC4U, an immunology company developing innovative treatments for auto-immune diseases and allergies, has been awarded a €1.7m Eurostars (SiaDM) grant, together with a Leiden University Medical Center (LUMC) research group, …
An international drive to highlight the importance of the prevention and adequate management of diabetes has been proposed by a team of the world’s leading experts on diabetes, following a …
A leading charity partnership is urging more people to check their risk of Type 2 diabetes through a free online tool as new figures reveal an acceleration of diagnoses in …
Researchers at the Massachusetts Institute of Technology (MIT) have developed a new drug capsule with a robotic cap for improved drug delivery. Because large-protein drugs generally cannot pass through the …
Use of an older class of Type 2 diabetes drugs called glitazones (also known as thiazolidinediones or TZDs) is linked to a 22% reduced risk of dementia, reveals a a …
The National Institute for Health and Care Research (NIHR) has announced a £26 million investment in an NIHR Leicester Biomedical Research Centre (BRC) – a partnership between the University Hospitals …
Eli Lilly plans to introduce a personalized diabetes management platform that integrates with technologies, including Dexcom’s continuous glucose monitoring (CGM) systems. The platform, branded Tempo, features a reusable medical device …
A team of University of British Columbia (UBC) researchers has discovered that insulin from the oral insulin tablets they are developing is absorbed by rats in the same way that …
People from ethnic minority and marginalised community groups are being offered advice on health issues that disproportionately affect them. The Bristol Community Health Day on 8 October saw grassroots health …
The US Food and Drug Administration (FDA) has approved Mounjaro (tirzepatide), Eli Lilly and Company’s new once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) injection, to be used as …
Diabeloop has developed an algorithm that is hosted on a dedicated handset and serves as a bridge between continuous glucose monitors and insulin pumps. Every five minutes, the handset receives …
Bariatric surgery has become more common as global rates of obesity have increased, but it may also raise the risk of developing epilepsy, according to new research. Analyzing health records, …
According to a study published in Diabetes Technology & Therapeutics, while closed-loop insulin delivery systems can increase glucose time in range and reduce hypoglycemia episodes (compared with sensor-augmented pump therapy) …
NHS England patients with Type 1 diabetes will now be eligible for life-changing continuous glucose monitors after the health service secured a new cut-price deal. These wearable arm gadgets send …
Diabetes costs the NHS around £10bn a year. It is a national priority and a focus of the NHS Long Term Plan. There are guidelines on diabetes management and NHS …
Verily’s Onduo has announced that it has entered into a strategic collaboration with Sword Health to broaden virtual care for diabetes and other conditions, as reported by Drug Delivery Business. …
A recent research study has found that childhood obesity is more common now than 12 years ago – which is particularly troubling news, given that obesity increases the risk of …
A new study has found that Vitamin D deficiency has a causative role in the systemic inflammation that commonly accompanies it, with inflammation declining as Vitamin D levels increase to …
Longenesis has announced that a study on Type 1 diabetes care, undertaken in partnership with Medtronic, has demonstrated that insulin pump use supports a higher quality of life. Across less …
Zillion has announced a partnership with Dexcom, the leader in real-time continuous glucose monitoring (CGM), to connect Dexcom CGM with Zillion’s platform for use with their RestoreHealth program. This partnership …
Among the news items in this issue is one about the need to move away from the relatively well-known concept of your BMI (body mass index) measurement being any sort …
Nintendo’s Animal Crossing game is getting a new diabetes-themed island designed by medtech company Insulet. This latest move towards ‘gamification’ sees diabetes charities teaming up with Insulet to “bring diabetes …
According to planet and environment news site www.earth.com, moderate to high consumption of black, green, or Oolong tea is associated with a lower risk of developing Type 2 diabetes. A …
According to an article in DiaTribe, researchers have suggested that the new drugs developed to help people with Type 2 diabetes to lose weight, lower glucose, and prevent complications could …
With the World Health Organisation (WHO) reporting that overweight and obesity has reached “epidemic proportions” in Europe, causing more than an estimated 1.2 million deaths every year, and ranking the UK …
Waist-to-hip ratio (WHR) is a stronger predictor of early death than body mass index (BMI) and should be considered as a superior measure of healthy weight, according to new research …
JDRF have announced a ‘Type 1 Diabetes Discovery Event & Technology Exhibition in Redmaids’ High School, Bristol between 10:00–5:30 on 29 October 2022. Held in association with the South West …
Abbott has announced new data from the Real World Evidence of FreeStyle Libre (RELIEF) study showing that the use of the FreeStyle Libre continuous glucose monitoring system (CGM) significantly reduces …
According to a recent article in Medscape, the treatment of people with obesity (but without diabetes) with the glucagon-like peptide-1 (GLP-1) agonist semaglutide led to beneficial changes in body mass …
After months of regulatory delays, Insulet has secured a CE Mark for its Omnipod 5, its automated Insulin Delivery System for individuals aged two years and older with Type 1 …
Diabetes research charity Juvenile Diabetes Research Foundation (JDRF) has published Our Impact 2021, “a glossy snapshot of everything JDRF achieved last year”, detailing how the charity believes it has delivered …
A set of policy recommendations have been drafted by the European Diabetes Forum (EUDF), emphasising the importance of digitalisation, data registries and integrated care to improve the quality of diabetes …
In Type 1 diabetes, the body develops immune cells that target pancreatic beta cells, which play a critical role in the production and secretion of insulin. One of the earliest …
Wrist-worn devices like smartwatches and fitness trackers appear to be cost-effective ways of screening for atrial fibrillation (AF) among high-risk people ages 65 and over, according to the results of …
Diabetes UK’s third annual Type 1 & Tech conference returns on Saturday 15 October 2022 from 10am to 2.30pm BST. The online conference, for people living with Type 1 diabetes, …
Learning to ride a bike or getting out for a walk could soon be just what the doctor ordered under new health plans noted by an article in Metro on …
In a recent article in Medscape, Ania Jastreboff, MD, PhD explains how, when patients with obesity come to her, “I look for the opportunity to share with them that obesity is …
Metformin is the first drug prescribed to most new patients with Type 2 diabetes and is increasingly popular for use with patients with Type 1 diabetes. It is inexpensive, available …
Zillion has announced a partnership with Dexcom, a leading provider of real-time continuous glucose monitoring (CGM), to connect Dexcom CGM with Zillion’s platform for use with their RestoreHealth program. This …
After receiving an FDA green light for the project earlier this year, Dexcom is now making its diabetes data available through consumer electronic devices. Leading the way is Garmin, with …
While zero-calorie sweeteners bring a little sweetness to our lives without prompting significant or obvious blood sugar spikes and are said to pass through the body without significant interaction with …
Adults with Type 1 diabetes experience ‘diabetes distress’, even when using continuous glucose monitoring (CGM), according to findings presented at the Association of Diabetes Care & Educational Specialists Annual Conference. …
Abbott has announced that it has entered into a strategic partnership with WeightWatchers to help people living with diabetes. The companies will work together to integrate WeightWatchers’ diabetes-tailored weight management …
Funding for a five-year project that aims to develop a new type of care package that addresses gaps in support for people under 40 living with Type 2 diabetes, has …
Our September issue is packed full of news. Some about medications, some about vitamins (well, vitamin D in particular) as well as device updates. Insulin pumps and CGMs are centre-stage …
One Drop has announced outcomes from a study on the effects of the AI-powered blood glucose (BG) forecasting feature of its One Drop digital health platform. One Drop is the …
In diabetes, foot ulcers are such a common complication that they account for almost 1% of the total NHS budget and can lead to amputations and premature death. While they …
COUR Pharmaceuticals has published details of a study with the Miller Lab at Northwestern University, in which treatment with the COUR NanoParticle Platform (CNP) prevented beta cell destruction in the …
Sanofi and Roche have joined forces in France to drive adoption of a connected add-on for disposable insulin pens. The partners will jointly develop a scientific program for physicians and …
A set of policy recommendations have been drafted by the European Diabetes Forum (EUDF), emphasising the importance of digitalisation, data registries and integrated care to improve the quality of diabetes …
The Diabetes Research & Wellness Foundation (DRWF) has announced that its fourth annual Diabetes Wellness Day Midlands will be held on 24th September at Chesford Grange, Warwickshire. The day aims …
Australia could become the first country to adopt routine childhood screening to detect Type 1 diabetes in children, if a new national screening research pilot for Type 1 diabetes funded …
A recent study has found that low serum levels of vitamin D were significantly associated with a higher prevalence of diabetic foot ulcers (DFUs) in elderly patients with diabetes. Vitamin …
Type 2 diabetes is a well-established risk factor for dementia and Parkinson’s Disease (PD), but according to a report by Marlene Busko in Medscape, a recent observational study of more …
New legislation to allow a wider range of healthcare professionals to certify so-called ‘fit notes’ has been laid before the UK Parliament. From 1 July 2022, nurses, occupational therapists, pharmacists, …
Diabetic macular oedema (DME) is one of the most common diabetes-related eye complications and causes of vision loss (c12% of people with Type 1 and 28% of people with Type …
Following new guidelines from the National Institute for Care and Excellence (NICE) which recommends that adults with Type 1 diabetes should be offered a choice of glucose sensor, children should …
Insulet Omnipod As reported in August 2022 by MedTechDive,The Omnipod 5 is one of two insulin pumps manufactured by the company that can be purchased through pharmacies, which Insulet said …
Can a beer a day keep the doctor away? New research from Portugal found that men who drank one can of alcoholic or nonalcoholic lager a day for four weeks …
LiveMetric has announced the launch of LiveOne, the world’s first U.S. Food and Drug Administration (FDA)-cleared nano-sensor technology for monitoring blood pressure every 10 seconds. LiveOne is a wrist-worn, cuff-free …
Diabetic neuropathy is a form of nerve damage that may occur in people with diabetes, linked to heightened blood sugar levels. It most commonly affects the nerves in the legs …
After decades of having to juggle multiple devices and fingerprick systems to take their own blood sugar readings and use them to calculate insulin dosages, people with diabetes now have …
This award is supported by all the main diabetes professional organisations and charities as well as Desang, and is now in its 12th year. It is sponsored by the pharmaceutical …
The American Diabetes Association(ADA), has applauded U.S. Senators Jeanne Shaheen (D-NH) and Susan Collins (R-ME) for recently introducing legislation which aims to make insulin more affordable for millions of Americans …
All 130,000 Australians with Type 1 diabetes will now get access to subsidised continuous glucose monitoring (CGM) devices under the newly-elected Australian Prime Minister Anthony Albanese’s National Diabetes Services Scheme …
The InDependent Diabetes Trust (IDDT) have announced another one-day event at the Kettering Park Hotel on Saturday 29 October 2022. Entitled ‘Changing Times’ to reflect some of the issues that …
Although things do tend to be a little quieter over the summer months, the fact is that this is another issue filled-to-busting with news and features. Frankly there’s a rather …
Vertex to acquire ViaCyte, with the goal of accelerating its potentially curative VX-880 programmes in Type 1 diabetes. ViaCyte brings tools, technologies and assets with potential to accelerate development of …
An international team of scientists led by Anglia Ruskin University (ARU) has announced “extremely positive results” from laboratory trials of a compound that could one day offer a non-operative option …
The latest issue of Type 1 Discovery magazine, which aims to give the latest news, events, features and research updates about Type 1 diabetes and JDRF (a US-based non-profit organisation …
ViCentra is closing its UK operations for the time being due to current supply issues. Two years ago ViCentra withdrew the product from the UK market. Meanwhile, the company has …
The BBC has reported that the NHS has been awarded the George Cross by Her Majesty The Queen, accompanied by His Royal Highness The Prince of Wales. The George Cross …
According to new research at the University of Chicago, the causes of Type 1 diabetes focus on auto-immune response, in which the immune system shatters the islets of Langerhans, which …
At the American Diabetic Association (ADA) 82nd Scientific Sessions, a panel of experts shared some impressive results from a recent trial of the iLet Bionic Pancreas pivotal trial, claimed to …
With the Met Office issuing weather warnings for extreme heat in areas of the country this weekend and into next week, Diabetes UK Cymru has put out advice for how …
As reported by DiaTribe, Dr. Ania Jastreboff, of the Yale University School of Medicine, and colleagues have presented new data which has investigated the effectiveness of Tirzepatide for the treatment …
At the American Diabetes Association 82nd annual Scientific Sessions, Vertex Pharmaceuticals released new data from a trial of two participants receiving a stem cell-derived beta cell therapy for Type 1 …
The national Children and Young People’s Mental Health (CYPMH) Team at NHS England and Improvement are recruiting four national lived experience partners to work in a new role with the …
Obesity in adolescence linked to T1D in adulthood. Excessively high body mass index (BMI) in late adolescence has been linked to development of Type 1 diabetes, not just Type 2 …
I think that 10 years ago I was doubtful that CGM technology would become a reality, but it has. I wonder what the diabetes world will be like in another …
Insulet’s Omnipod 5 ‘significantly Improves’ glycaemic outcomes in very young children. Insulet has announced that its Omnipod 5 tubeless, wearable, automated insulin delivery system can significantly improve time in range …
For healthy middle-aged and older adults, adding cranberries to the diet may help improve memory and brain function, as well as lower LDL cholesterol, new research suggests. A trial of …
Research project seeks older Type 2s on insulin, an update. By Susannah Hickling. Researchers at King’s College London are stepping up recruitment of older people with Type 2 diabetes who …
A small whey protein drink taken 10 minutes before meals can significantly lower 24-hour mean blood glucose concentration and increase the amount of time people with diabetes spend in euglycaemia …
New research has found that some cosmetic products can contain enough biotin to interfere with several laboratory test results, including those of thyroid function, Study coauthor Saleh Aldasouqi, MD, of …
A trial of insulin-producing arm implants have been reported as promising. According to a report in Hospital + Heatlhcare, a trial at the Royal Adelaide Hospital (RAH), in which insulin-producing …
By joining this study, you could contribution to greater understanding of how low blood glucose affects our quality of life, an update by Susannah Hickling. A research study that …
Having already received a CE mark in September 2020 for FreeStyle Libre 3 (FSL3), the latest version of its continuous glucose monitor, Abbott has now received 510(k) clearance from the …
Fewer than one in four women with a history of gestational diabetes (sudden onset diabetes in pregnancy) are later screened for signs of T2D despite the fact they are known …
A NovoRapid PumpCart insulin cartridge and Roche Accu-Chek Insight insulin pump safety warning has been issued. The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a safety warning, following …
The drug regulator NICE (the National Institute for Health and Care Excellence) has recommended the Sleepio app as an effective alternative to sleeping pills. Nearly a hird of adults in …
Bakul Patel, the chief digital health officer at America’s influential Food and Drug Administration which approves new drugs and regulates healthcare in the USA, has announced he is moving to …
A new drug called Mounjaro (tirzepatide) manufactured by Eli Lilly and shown to dramatically lower excess weight as well as blood glucose in clinical trials, has just been approved for …
After years of dithering on the damaging effects of BOGOF (Buy One Get One Free) deals offered by supermarkets on sweets, snacks and junk food, the prime minister has caved …
The Sheffield branch of Diabetes UK has embarked on a new initiative to prevent people suffering worsening symptoms of the condition. People of all ages and fitness levels (or lack …
Updated NICE guidelines where all Type 1s will be offered a choice of CGMs as well as access to an insulin pump (as well as some Type 2s). Short-term costs …
Many people have successfully lost weight by having days when they don’t eat and now a year-long Chinese study has suggested time-restricted eating might be better than just eating the …
A study that followed more than 110,000 men and women for more than 30 years claims to have shown that eating two servings of avocado a week reduces the risk …
New statistics from the charity Diabetes UK reveal thousands of people are struggling to access diabetes care with little more than a third of people living with the condition receiving …
There has been an historic £50m investment from the Steve Morgan Foundation into Type 1 diabetes research. The donation – the largest ever single gift in the UK for diabetes …
Another new innovation in personalised diabetes management has been introduced by the French company Diabeloop. Their new DBL-4pen is designed for people who can’t or don’t want to wear an …
Doctors have long been reluctant to treat obesity as a disease, arguing that if the element of personal responsibility is removed, people are inclined to view their weight gain as …
Billions of plastic pre-filled disposable insulin pens are distributed globally every year, making a massive contribution to the environmental disaster facing all of us. At the end of last year …
‘Control sugar levels sooner to guard against heart attacks’ finds new study into Type 2 diabetes. People with Type 2 diabetes may need to reduce their blood sugar levels sooner …
It is known that obesity increases the risk of developing T2D but one in ten sufferers are not obese or overweight. Results from a study by Professor Roy Taylor of …
A law introduced this month will require all cafes, restaurants and takeaways with more than 250 employees to list calorie counts on non-prepacked food and soft drinks. Critics are generally …
A once-weekly 2mg injection of Novo Nordisk’s Ozempic semaglutide product Ozempic has been approved for use in America, following results of the SUSTAIN FORTE trial, which showed that a higher …
There are good reasons to try to control T2D by weight loss. The biggest study to date, involving 3m people with an average age of 50, compared health data of …
This has been a fun issue to oversee. The new NICE guidelines are pretty amazing. All Type 1s and some Type 2s to get access to a choice – a …
Every day is ‘A Day’ in PR land and a group of companies that make standing desks and other ‘active office’ equipment has collaborated to come up with On Your …
Nemaura Medical, manufacturer of the sugarBEAT continuous glucose monitor sold in the UK through MySugarWatch, and the Miboko body worn glucose sensor, has just received prizes for Innovator of the …
One in four children and young adults aren’t diagnosed with T1D until they have potentially fatal diabetic ketoacidosis – when the body doesn’t have enough insulin to allow blood sugar …
The drive towards personalised care continues with the development of new software called the Healum app. Results of an 18-month trial presented at the Diabetes UK professional conference in March …
By Sue Marshall, editor, Desang Diabetes Magazine As I said in the editorial of the latest issue of the magazine, which went out last week,when I set the magazine up, …
Dexcom, fresh from celebrating gaining a CE Mark for its G7 sensor, has also announced another new product, Dexcom ONE. This is expected to be on prescription via the NHS …
The Diabeloop system. NICE guidelines on Type 1 diabetes in adults: diagnosis and management (ng17) This update to the guideline regarding diagnosis and glucose monitoring has now been published on …
The Welsh division of Diabetes UK is trumpeting the success of 13-year-old Olivia Bant from Cardiff, who after three years of trying to conceal her Type 1 diabetes from friends, …
Diabetes UK Cymru has appointed Rachel Burr as the organisation’s new National Director. As part of Diabetes UK, Diabetes UK Cymru supports people living with the condition, campaigns for improved care, …
When I set this magazine up, the point was to share information and talk about diabetes ‘kit’. Back then (about a decade ago), few people wore, or had even …
More than three quarters of Britons have tried to lose weight by dieting but only a fifth of them said successful dieting had made them happier, according to new research …
After a two-year absence Diabetes UK is once more holding a 10-mile fund-raising river Thames ‘wellness walk’ in West London on 8 May to raise funds and remind people of …
The Swedish health-tech company Brighter has signed an agreement with the Northern Care Alliance NHS Trust to set up a research project to demonstrate the benefits of its product Actiste …
Stretchy skin-like wearable electronic devices are just around the corner, offering the chance to transform the lives of millions of people living with diabetes who are currently obliged to make …
The InDependent Diabetes Trust (IDDT) has been contacted by people in Ukraine in need of diabetes medical supplies. IDDT’s CEO Martin Hirst told us, “The Independent Diabetes Trust started an …
Abbott, the global healthcare company, today announced that its FreeStyle Libre 3 continuous glucose monitoring (CGM) system, the latest addition to the world-leading FreeStyle Libre sensor technology, is now available …
A resource has been created by JDRF UK in association with JDRF International, JDRF Australia and the Beyond Type 1 Alliance. It will be updated as more information becomes available. …
The French pharmaceutical giant Sanofi has agreed to pay digital health company Dario Health $30 million to market its diabetes products. In return, Dario Health will have access to Sanofi’s …
University College London’s Global Business School for Health has partnered with the pharmaceutical company Roche UK to offer a new fully-funded MBA Health scholarship open to girls or to black, …
There are very many reasons to be thankful for the unique level of healthcare offered free by the NHS in Britain. In America insulin manufacturers have cynically hiked their prices …
Side by Side – Dexcom G6 (left) and G7 (right) Dexcom’s G7 is the next-generation continuous glucose monitoring (CGM) system building on the best-selling real-time CGM in the world. It …
Although there has been much discussion about sharing electronic health records, information from home wearable devices is not shared with outpatients clinics or hospitals so doctors never get a full …
A team led by mechanical engineers from the Massachusetts Institute of Technology (MIT) in America has patented two new devices to reduce the rigmarole of diabetes management. One is a …
More than nine out of ten surgeons say they have pricked themselves with a contaminated needle at least once or seen a colleague do so. The Royal College of Nursing …
Many of the UK’s biggest restaurant chains have told the Observer newspaper they won’t change their ingredients when regulations are introduced in April requiring them to include calorie counts for …